August - 2017
| Previous Next | Showing Journal 2 of 9 |
Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical TrialGM Felker, KJ Anstrom, KF Adams, et al JAMA, 2017, 318(8):713-720 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
August |
Previous Comments
No Comments yet.
Comment
Does titrating anti-heart failure therapy to a target amino-terminal pro–B-type natriuretic peptide (NT-proBNP) level improve clinical outcomes in patients with heart failure and reduced ejection fraction (<40%)? Over the last 2 decades various studies have tested this...